By Dennis Thompson HealthDay ReporterTUESDAY, June 10, 2025 (HealthDay News) — Blood tests can detect evidence of cancer three years earlier than the disease would otherwise be diagnosed, a new ...

FDA approves first blood test for Alzheimer's detection. Simple blood draw replaces expensive scans and spinal taps.

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase access to Alzheimer’s detection and reduce reliance on expensive ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline.

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of ...

FDA endorses first-of-its-kind blood test for Alzheimer’s disease The test is designed to detect amyloid plaques in the brain for patients with symptoms.

The Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, the regulator said today, making the device the first of its kind to detect the ...

Learn what happens during an ESR test, how to interpret your results, and why this simple blood test remains a crucial tool for detecting inflammation.

In a report released today, Ben Wong from DBS maintained a Buy rating on ESR Group Limited (1821 – Research Report), with a price target of HK$14.31.

The MCHC blood test measures the concentration of hemoglobin in red blood cells, helping diagnose anemia and other blood disorders.

Scientists have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for pancreatic cancer.